Liver cancer has become the sixth most diagnosed cancer and the fourth leading cause of
cancer death worldwide. Hepatocellular carcinoma (HCC) is responsible for up to 75–85 …

Hepatocellular carcinoma (HCC) is one of the most common causes of cancer‐related
deaths globally due, in part, to the majority of patients being diagnosed with intermediate or …

Background and aims Accumulating evidence suggests that the primary and acquired
resistance of hepatocellular carcinoma (HCC) to sorafenib is mediated by multiple …

Hepatocellular carcinoma (HCC) accounts for about 90% of all primary liver cancers and is
the second leading cause of cancer-related deaths worldwide. The hypervascular nature of …

Importance Liver cancer is among the leading causes of cancer deaths globally. The most
common causes for liver cancer include hepatitis B virus (HBV) and hepatitis C virus (HCV) …

Sorafenib, a multikinase inhibitor with antiproliferative, antiangiogenic, and proapoptotic
properties, constitutes the only effective first-line drug approved for the treatment of …

Hepatocellular carcinoma (HCC), also called malignant hepatoma, is one of the deadliest
cancers due to its complexities, reoccurrence after surgical resection, metastasis and …

Hepatocellular carcinoma (HCC) is the second deadliest cancer worldwide, due to its high
incidence and poor prognosis. Frequent initial presentation at advanced stages along with …

The prevalence of hepatocellular carcinoma (HCC) is increasing worldwide, whereas that of
most other cancers is decreasing. Non-alcoholic fatty liver disease (NAFLD), which has …

Apigetrin (7-(β-D-glucopyranosyloxy)-4′, 5-dihydroxyflavone), a glycoside bioactive dietary
flavonoid derived from Taraxacum officinale and Teucrium gnaphalodes, is known to …